Notice ID: 787849600a224b2a81032d9f021aaaeaAward NoticeAwarded
SECURE DOCUMENT SHREDDING SERVICES
Awarded on September 28, 2026. The description is published on SAM.gov: Full description on SAM.gov.
Awarded tounder 7571PS26D00002 (source: SAM.gov award notice)• $224.1K
Description
No description in the SAM.gov data feed for this notice.
Overview
Agency:
Department of Health and Human ServicesOFFICE OF THE ASSISTANT SECRETARY FOR FINANCIAL RESOURCES (ASFR)
Office:OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES
Posted:October 1, 2026
NAICS:Not specified
Last Updated:Oct 13, 2026
PSC:Not specified
Set-Aside:Not specified
Type:Award Notice
Place of Performance:51595, District of Columbia
Award Date:Sep 28, 2026
Award Amount (SAM.gov award notice):$224.1K
Award Overview
Award Number
7571PS26D00002
Award Amount (SAM.gov award notice)
$224.1K
Award Date
Sep 28, 2026
Awardee
Awardee UEI
G66PMEXTJKS7
Awardee CAGE Code
6RXM6
Awardee Address
Baltimore, MD 21223, UNITED STATES
Original Solicitation
Notice ID: 787849600a224b2a81032d9f021aaaea
Posted Date: Oct 1, 2026
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Michael Gemmill
Documents
No documents available.
Lifecycle
Solicitation:
7571PS26D00002- Awarded
This opportunity has been awarded.
- AwardedCurrentOct 1, 2026
SECURE DOCUMENT SHREDDING SERVICES
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
In accordance with GSAM/R 538.7104-3(b)(3)(ii)(A), the attached Sole Source Justification is provided for an urgent bridge extension awarded to Deloitte Consulting LLP under 47QRAA18D001P/75ACF121F80033, to ensure uninterrupted, critical mission support services while the competitive follow-on contract is finalized and awarded. | Sole Source / J&A | 541611 | No Set-Aside | 10/16/2026 | Open | 80704, DC | |
The Centers for Disease Control and Prevention (CDC) awarded a sole source contract with MATHEMATICA INC., 1100 1ST ST NE FL 12, WASHINGTON, DC. 20002 This notice is provided in accordance with RFO FAR 8.401 & GSAM/R 538.7104-3(b)(1) . Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases (DBD) requires support Services with the contractor listed above. The requested contractor Mathematica qualified as “innovator status” vendor for data analysis by Center for Medicare and Medicaid Services (CMS). Mathematica also has demonstrated experience and specialized staff with unique access and analytical capabilities for Medicaid data sets which captures the largest segment of US healthcare data, including births. The contractor shall perform analyses across four technical dimensions defined in the Statement of Work: (1) validating infant GBS case counts using TAF OT claims and evaluating a fourth case definition tied to maternal Medicaid IDs; (2) developing and refining a probabilistic mother-infant linkage algorithm using the Medicaid Case Number and supplementary variables; (3) estimating maternal vaccination coverage (COVID-19, influenza, Tdap, and prospectively RSV) accounting for bundled payment code effects; and (4) applying methods to reduce gestational age missingness using prenatal claims data. These tasks require continuity with linkage algorithms and case-definition logic Mathematica has already built and validated under prior CDC task orders. The authority permitting other than full and open competition is Title III of the Federal Property and Administrative Services Act of 1949 (41 U.S.C. 251, et seq.); Title 40 U.S.C. 501, Services for Executive Agencies, as implemented at FAR 8.401 and GSAM/R 538.7104-3(b)(1) "Only one source is capable of providing the products, services, or solution required at the level of quality required because the products, services, or solutions are unique or highly specialized." Through its prior contracts, Mathematica has already built key parts of this analysis—including updating the medical codes used to identify cases, working to link mother and infant records more completely, and adjusting for how individual states handle Medicaid enrollment for newborns. This steady, hands-on progress means Mathematica starts this next phase of work already ahead, with the knowledge and tools in place that a new contractor would not have. All responsible sources may submit a capability statement, proposal, or quotation to Robin C. Meyer, Contract Specialist, at rcm2@cdc.gov, which shall be considered by the agency. The deadline for submissions is Ocotber 31, 2026 at 4:30PM EST. The Government will review any/all information submitted to determine if other responsible sources exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement. | Special Notice | 541611 | No Set-Aside | 10/16/2026 | 10/31/2026 | - | |
Amendment 0002 to Solicitation BARDA-27-100227, Device Development for Scientists Training, provides a revised RFQ and Performance Work Statement (PWS) and publishes the Government’s responses to questions. Quotations are due October 21, 2026, at 1:00 p.m. Eastern Time. The October 6, 2026, deadline for questions remains unchanged. AMENDMENT 0001 08 October 2026: The quote due date is extended to 1 pm ET on October 21, 2026, unless a further amendment is issued. Questions and answers will be posted to this notice. The RFQ and PWS will be revised and posted prior to the quote due date. Offerors should review the updated documents before submitting a quotation. See attached Amendment 0001. The objective of this requirement is to obtain a qualified Contractor to provide a two-day, in-person, instructor-led training course on Device Development for Scientists. The Government is finalizing the training dates, which will be stated in the revised RFQ and PWS. The training shall provide participants with an understanding of the scientific, clinical, regulatory, intellectual property, and commercial considerations involved in medical device development and bringing medical devices to market. | Solicitation | 611430 | Total Small Business Set-Aside | 10/14/2026 | 10/21/2026 | Washington, DC | |
Amendment 1 (10/14/2026): Update due dates and/or times of all TAs SPECTRA will identify and act on autism trajectories, the evolving developmental paths individuals follow across the lifespan from the prenatal period through aging, spanning autism characteristics, co-occurring conditions, and functional outcomes together with the genetic, biological, behavioral, iatrogenic (medical influences), environmental factors and their nonlinear interactions. Rather than examining these factors in isolation, SPECTRA will examine how they combine and interact, including their nonlinear interactions, to produce autism and its co-occurring conditions over time. SPECTRA will also develop technologies that serve two purposes at once: extending reliable assessment beyond the clinic while improving everyday communication, function, and quality of life. The same tools people use to live more fully will also generate the data that drive measurement and personalized care. | Solicitation | 541715 | No Set-Aside | 10/14/2026 | 10/21/2026 | - | |
J&A to extend Period or Performance for procurement of Inmazeb. | Sole Source / J&A | 541714 | No Set-Aside | 10/10/2026 | Open | 75496, NY |
Additional Details
Solicitation Number
7571PS26D00002
Archive Date
Oct 13, 2026
Office Address
Rockville, MD, 20857